NCT06866860

Brief Summary

Background: Patient specific surgical guides (PSG) have been widely used to achieve a precise 3D implant position. However, they prevent external cooling systems from reaching the osteotomy site sufficiently. So, heat generated during guided implant surgery is greater than free hand technique. Adding internal irrigation channel to the conventional surgical guides allows better diffusion of irrigation to the osteotomy site and reduces heat generation. Aim of the study: Is to introduce a patient specific surgical guide design with internal irrigation system and compare it to the conventional surgical guide with external irrigation clinically through bone temperature, implant stability and radiographically by CBCT through crestal bone loss and bone density.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 4, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 17, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 17, 2024

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

March 2, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 10, 2025

Completed
Last Updated

March 10, 2025

Status Verified

March 1, 2025

Enrollment Period

7 months

First QC Date

March 2, 2025

Last Update Submit

March 6, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • change in implant stability

    Osstell will be used to objectively and non-invasively determine implant stability and to assess the progress of osseointegration without jeopardizing the healing process. This method is based on determining whether or not an implant is stable enough. The result is presented as an ISQ value of 1-100. The higher the ISQ, the more stable the implant

    Baseline and 4 months

  • change in postoperative oedema

    This will be measured as follows: None (no inflammation). Mild (intraoral swelling confined to the surgical field). Moderate (extraoral swelling in the surgical zone). Severe (extraoral swelling spreading beyond the surgical zone).

    2nd day, 1 week and 2 weeks

Secondary Outcomes (3)

  • Presence of intra or postoperative complications

    4 months

  • change in crestal bone loss

    baseline and 4 months

  • change in bone density

    baseline and 4 months

Study Arms (2)

Study group

EXPERIMENTAL
Other: Implant surgical guide with internal irrigation

Control group

ACTIVE COMPARATOR
Other: Conventional implant surgical guide with external irrigation

Interventions

* Virtual surgical plan will be completed in the implant planning software (BlueSky plan, BlueSky Bio, USA), and the implant type, position, and sleeve height will be adjusted. * The entry point of the surgical drill into the alveolar bone will be identified. * An irrigation channel will be added, directed toward the entry point of the drill and adjusted to have the same diameter as the irrigation system tube.

Study group

Virtual surgical plan will be completed in the implant planning software (BlueSky plan, BlueSky Bio, USA), and the implant type, position, and sleeve height will be adjusted. Conventional guide will be printed

Control group

Eligibility Criteria

Age20 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patient with missing mandibular posterior premolar or molar teeth.
  • Tooth extraction at the implant sites was performed at least 4 months before the surgery.
  • Residual alveolar bone height more than 10 mm.
  • With minimum alveolar bucco-lingual dimension of 6 mm.
  • Free from any systemic disease or local pathological lesions that may affect bone healing or contraindicate implant placement.

You may not qualify if:

  • Severe atrophic alveolar ridge (height less than 10mm, width less than 6mm).
  • Bad oral hygiene ( Silness-Löe index (score 2-3).
  • Heavy smoker (smoke greater than or equal 25 cigarettes per day).
  • Presence of acute infections or periapical lesions in adjacent teeth.
  • Parafunctional habits.
  • Pregnant females.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Outpatient Clinic of Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Alexandria University, Egypt

Alexandria, Azarita, 00203, Egypt

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant Lecturer of Dental Public Health and biostatistical consultanat

Study Record Dates

First Submitted

March 2, 2025

First Posted

March 10, 2025

Study Start

April 4, 2024

Primary Completion

October 17, 2024

Study Completion

October 17, 2024

Last Updated

March 10, 2025

Record last verified: 2025-03

Locations